Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.
Saved in:
| Title: | Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS. |
|---|---|
| Authors: | Price, David (AUTHOR), Henley, William (AUTHOR), Cançado, José Eduardo Delfini (AUTHOR), Fabbri, Leonardo M (AUTHOR), Kerstjens, Huib AM (AUTHOR), Papi, Alberto (AUTHOR), Roche, Nicolas (AUTHOR), Şen, Elif (AUTHOR), Singh, Dave (AUTHOR), Vogelmeier, Claus F (AUTHOR), Nudo, Elena (AUTHOR), Carter, Victoria (AUTHOR), Skinner, Derek (AUTHOR), Vella, Rebecca (AUTHOR), Soriano, Joan B (AUTHOR), Kots, Maxim (AUTHOR), Georges, George (AUTHOR) |
| Source: | Pragmatic & Observational Research. Jan2024, Vol. 15, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11797266 |
|---|---|
| DOI: | 10.2147/POR.S438031 |
